Inhibition of camel lens ζ-crystallin by aspirin and aspirin-like analgesics

被引:4
|
作者
Bazzi, MD [1 ]
Rabbani, N [1 ]
Duhaiman, AS [1 ]
机构
[1] King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia
关键词
camel lens; zeta-crystallin; inhibition; aspirin;
D O I
10.1016/S1357-2725(01)00099-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Camel lens zeta-crystallin was reversibly inhibited to various degrees by aspirin (acetyl salicylic acid) and the aspirin-like analgesics: paracetamol (acetaminophen) and ibuprofen (2-(4-isobutyl phenyl)-propionic acid). Among these. aspirin was the most potent inhibitor. causing nearly complete inhibition in a dose-dependent, but time-independent manner. Analysis of inhibition kinetics revealed that aspirin was uncompetitive inhibitor (K-i 0.64 mM) with respect to NADPH and non-competitive inhibitor (K-i 1.6 mM) with respect to the substrate, 9.10-phenan-threnequinone (PQ). Multiple-inhibition analysis showed that aspirin and pyridoxal 5' phosphate (PAL-P), a lysine specific reagent. simultaneously bound to a critical lysine residue located towards the NADPH binding region. Consistent with this. NADPH was able to substantially protect zeta-crystallin against aspirin. whereas PQ did not provide any protection. The results suggested that an essential lysine residue was the locus of aspirin binding. The inhibition of zeta-crystallin by aspirin and aspirin-like analgesics was reversible thus eliminating acetylation as a mechanism for inhibition. Reversible binding of aspirin to this lysine may cause steric hindrance resulting in uncompetitive inhibition with respect to NADPH. (C) 2001 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [21] INHIBITION OF PROSTAGLANDIN SYNTHETASE BY ASPIRIN-LIKE DRUGS IN DIFFERENT MICROSOMAL PREPARATIONS
    DEMBINSKAKIEC, A
    ZMUDA, A
    KRUPINSKA, J
    ADVANCES IN PROSTAGLANDIN AND THROMBOXANE RESEARCH, 1976, 1 : 99 - 103
  • [22] DIFLUNISAL, AN ASPIRIN-LIKE ANALGESIC AND ANTIINFLAMMATORY DRUG
    VANARMAN, CG
    RISLEY, EA
    LOTTI, VJ
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1037 - 1037
  • [23] ACYLATION OF HEMOGLOBIN BY ASPIRIN-LIKE DIACYL ESTERS
    MASSIL, SE
    SHI, GY
    KLOTZ, IM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (07) : 1013 - 1014
  • [24] PROSTAGLANDINS, ASPIRIN-LIKE DRUGS AND EDEMA OF INFLAMMATION
    MONCADA, S
    FERREIRA, SH
    VANE, JR
    NATURE, 1973, 246 (5430) : 217 - 218
  • [25] CENTRAL ANALGESIC EFFECTS OF ASPIRIN-LIKE DRUGS
    BANNWARTH, B
    DEMOTESMAINARD, F
    SCHAEVERBEKE, T
    LABAT, L
    DEHAIS, J
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (01) : 1 - 7
  • [26] CITATION CLASSIC - INHIBITION OF PROSTAGLANDIN SYNTHESIS AS A MECHANISM OF ACTION FOR ASPIRIN-LIKE DRUGS
    VANE, JR
    CURRENT CONTENTS/LIFE SCIENCES, 1980, (42): : 12 - 12
  • [27] If the patient told the truth: aspirin-like defect
    Wolf, Z.
    Schindewolf, M.
    Lindhoff-Last, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 935 - 935
  • [28] ASPIRIN-LIKE DRUGS MAY BLOCK PAIN INDEPENDENTLY OF PROSTAGLANDIN SYNTHESIS INHIBITION
    BRUNE, K
    BECK, WS
    GEISSLINGER, G
    MENZELSOGLOWEK, S
    PESKAR, BM
    PESKAR, BA
    EXPERIENTIA, 1991, 47 (03): : 257 - 261
  • [29] PROSTAGLANDIN SYNTHETASE AND MECHANISM OF ACTION OF ASPIRIN-LIKE DRUGS
    VANE, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1976, : 8 - 8
  • [30] THE PROSTAGLANDIN PARADOX - ADDITIVE INHIBITION OF NEUTROPHIL FUNCTION BY ASPIRIN-LIKE DRUGS AND PROSTAGLANDINS (MISOPROSTOL)
    KITSIS, E
    GUDE, D
    WEISSMANN, G
    ABRAMSON, S
    CLINICAL RESEARCH, 1990, 38 (02): : A317 - A317